With our mission to increase and share neurological excellence in Europe and to support neurologists in training during their education, EAN will give 60 neurologists in training the chance to participate in the new Autumn School to increase their knowledge… Continue Reading

  The new CME article May 2018: “Value of Clinical Features to Differentiate Refractory Epilepsy from Mimics – A prospective longitudinal cohort study” is online now! Please log-in and browse to the LEARN section on the EAN Website and answer… Continue Reading

  The democratic body of the European Academy of Neurology (EAN) is the assembly of delegates, which acts as the parliament of the EAN. This assembly meets once a year, usually on Saturday, during the annual meeting. The 4 major… Continue Reading

The EAN established an office in Brussels located within the University Foundation a long time established institution founded in 1920 to promote scientific activity at Belgian universities. Over time, this scope was enlarged and the Foundation now hosts an important number of academic societies such as EAN, FENS - Federation of European Neuroscience Societies, EURORDIS – European Organisation for Rare Diseases, EPA – European Psychiatric association etc.

Starting at the EAN congress 2018 in Lisbon, the EAN Teaching Course sub-Committee has proposed to have an educating AND entertaining quiz-show. A dedicated taskforce together with the support of the EAN Scientific Panels worked on the set-up of this educational session – the EAN BrainChallenge.

  Join us at the RRFS booth During the conference, RRFS members will be available at the LEARN and HOME area of the EAN booth in order to provide up-to-date information about membership, travel/EBN grants and other conference activities.  … Continue Reading

Please find below articles from Belarusan authors and co-authors that were published in the European Journal of Neurology

Prof. David B. Vodušek (DVB): Dear Prof. Zuberi I congratulate you with your new position as President of the EPNS. EAN addresses clinical neurology and needs to broaden its spectrum also towards clinical neuro-pediatrics. Kindly introduce the EPNS and its work to the readers of the EAN Pages Prof. Sameer Zuberi (SZ): Thank you. It is a special honour and a privilege for me to be elected as President of the EPNS. Our outgoing President, Lieven Lagae, deserves an enormous thank you from all of us— for guiding the society so ably.

  2017 was a remarkable year for EBC, thanks to the development of an increasing number of activities and new initiatives. In particular, the publication of EBC’s policy white paper on the “Value of Treatment for Brain Disorders in Europe”… Continue Reading

As in the previous years, EANpages asked EAN committee members, panel chairs, and invited speakers  which session one should not miss at the upcoming congress in Lisbon 2018. Please find their answers below!   Rolf Fronczek, MD, PhD
Dept. of… Continue Reading

  Portugal has a long tradition in the study of behavioral disorders, dating back to the work of Egas Moniz and his attempt to improve some psychosis with psychosurgery. In the early 1970’s Antonio Damasio, who was taking his PhD… Continue Reading

          by Anna Sauerbier         1) Depression study pinpoints genes that may trigger the condition https://www.eurekalert.org/pub_releases/2018-04/uoe-dsp041318.php   2) Practice makes perfect: The human brain can reprogram itself to control prosthetic limbs https://sciencebusiness.net/news/practice-makes-perfect-human-brain-can-reprogram-itself-control-prosthetic-limbs  … Continue Reading

As every year, spring time is high season for preparing for the annual congress - this year the 4th congress of the European Academy of Neurology in Lisbon. It is the annual main event of our Society and we expect around 6000 participants in this special and historically attractive Portuguese capital. The congress has continuously adapted its profile and one of the main goals of our Society is to continuously develop new formats which satisfy the requests of modern neurology and its drivers, the European Neurologists. Our program committee under the leadership of Prof. Boon has excellently realized this request with many new innovations.

For May 2018, we have selected: Kappos L, Bar-Or A, Cree BAC, et al., for the EXPAND Clinical Investigators. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomized, phase 3 study. Lancet Neurol 2018;391:1263-1273. Secondary progressive multiple sclerosis (SPMS) is characterized by a previous history of relapsing remitting MS (RRMS) and the continuous progression of disability over the years typically without relapses.

Portugal is a country with a 900-year history: many remnants of past colonization by Celtics, Romans, and Arabians are still present. Unquestionably, the greater contribution of Portugal to the humanity have been the overseas navigations around the world, namely the discovery of the maritime way to India, the discovery of Brazil and of several Atlantic islands.